SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 24, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

The insider sales are too small to carry informational content. Monitor for any larger insider transactions or changes in trading patterns, but this cluster alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$96.65
T+0 close · Jun 24, 2026 · via day close
Latest settled
+72.78%
T+60 · $166.99
Vs SPY
+69.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 25 $96.65entry
  2. T+1 · 5mo ago +3.30%α +4.02% · $99.84
  3. T+5 · 5mo ago +5.79%α +4.23% · $102.25
  4. T+20 · 4mo ago −4.36%α −4.88% · $92.44
  5. T+60 · 8w ago +72.78%α +69.05% · $166.99
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $203K in open-market transactions on June 22, 2026. The total value represents only ~0.004% of the company's $5.7B market cap, making this cluster immaterial and routine. No bearish signal is warranted given the trivial dollar amounts.

Key Financial Metrics

Direction
selling
Total Value
$203.0K
Insiders
3

Key Facts

  • CEO Emily Leproust sold 1,688 shares at $87.32 for $147K
  • SVP of HR Paula Green sold 291 shares at $87.32 for $25K
  • Executive Dennis Cho sold 346 shares at $87.32 for $30K
  • Total cluster value of $203K is ~0.004% of $5.7B market cap
  • All three sales occurred on the same day, suggesting a common liquidity or plan-driven event

Financial Impact

Trivial, $203K total sales, less than 0.01% of market cap

dilution

Risk Factors

  • Insider sales could precede a broader sell-off if they accelerate in size or frequency
  • Lack of insider buying alongside sales may indicate management is not aggressively bullish

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1782370790505

US Market Status

Market Closed · Opens Wed (13h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 25, 2026